Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Organoboron Intermediates. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN111217844A details a Cp2ZrCl2-catalyzed method for 1,1-diboronation. Offers high atom economy and scalability for pharma intermediates.
Patent CN110590821A details mild iridium-catalyzed synthesis. Offers cost reduction in pharmaceutical intermediates manufacturing with stable raw materials and high purity.